• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BCT 0.00% 0.3¢

BLUECHIIP LIMITED - Announcements

Bluechiip Limited is an Australia-based company, which is engaged in the development of... Bluechiip Limited is an Australia-based company, which is engaged in the development of advanced sample management solutions for harsh environments. The principal activity of the Company is the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. Its solutions include Bluechiip Enabled Solutions, Custom Solutions and Partnerships. The Company offers a range of services across product design, engineering and manufacturing. It also offers partners the ability to license its patented technology to differentiate their product and service offerings. The Company's Sample Storage solutions include Bluechiip Enabled CryoVial Range, Bluechiip Enabled CryoBoxes, Bluechiip Enabled CryoTags and a range of accessories for all advanced sample management needs. Its Readers solutions include Bluechiip Enabled Handheld Reader, Bluechiip Enabled Multivial Reader and Bluechiip Enabled CryoBox Tracker.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
BCT Broker PresentationPRICE SENSITIVE26/03/19
BCT Open BriefingPRICE SENSITIVE26/02/19
BCT Half Yearly Report and AccountsPRICE SENSITIVE25/02/19
BCT Appendix 4C - quarterlyPRICE SENSITIVE30/01/19
BCT Appendix 4C - quarterlyPRICE SENSITIVE18/10/18
BCT BCT raises $1.95M in Share Purchase PlanPRICE SENSITIVE03/10/18
BCT BCT Raises $5.5M and Announces Share Purchase PlanPRICE SENSITIVE10/09/18
BCT Trading HaltPRICE SENSITIVE06/09/18
BCT BCT signs three-year A$15.9M supply deal with LabconPRICE SENSITIVE29/08/18
BCT Preliminary Final ReportPRICE SENSITIVE28/08/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
BCT Open Briefing interview with MD Andrew McLellanPRICE SENSITIVE25/06/18 download Created with Sketch. 265.98KB
BCT Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
BCT Corporate Overview and March 2018 UpdatePRICE SENSITIVE14/03/18
BCT Open Briefing - 1H FY18 results and outlookPRICE SENSITIVE27/02/18
BCT Half Yearly Report and AccountsPRICE SENSITIVE26/02/18
BCT Labcon begins production of Bluechiip-enabled consumablesPRICE SENSITIVE19/02/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE22/01/18
BCT Bluechiip receives A$1M order from US PartnerPRICE SENSITIVE05/12/17
BCT Company update - scaling productionPRICE SENSITIVE19/10/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE17/10/17
BCT Preliminary Final ReportPRICE SENSITIVE30/08/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE27/07/17
BCT Bluechiip raises $3.425M from rights issue and placementPRICE SENSITIVE05/07/17
BCT Company UpdatePRICE SENSITIVE21/06/17
BCT Rights Issue Offer DocumentPRICE SENSITIVE05/06/17
BCT Rights IssuePRICE SENSITIVE01/06/17
BCT Open Briefing with MD/CEO Andrew McLellanPRICE SENSITIVE27/04/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE21/04/17
BCT Major Agreement Signed With Labcon North AmericaPRICE SENSITIVE10/04/17
BCT Half Yearly Report and AccountsPRICE SENSITIVE22/02/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE25/01/17
BCT CEO Interview / Open BriefingPRICE SENSITIVE08/12/16
BCT BCT receives funding for over-temperature R&DPRICE SENSITIVE17/11/16
BCT Sales of Starter Kits to two key institutionsPRICE SENSITIVE09/11/16
BCT Appendix 4C - quarterly-BCT.AX PRICE SENSITIVE25/10/16
BCT Partnership with Planet Innovation-BCT.AX PRICE SENSITIVE15/09/16
BCT Open Briefing - CEO Update-BCT.AX PRICE SENSITIVE09/09/16
BCT Technology Evaluation Agreement and patent application-BCT.AX PRICE SENSITIVE01/09/16
BCT Preliminary Final Report-BCT.AX PRICE SENSITIVE29/08/16
BCT Rights Issue - Variation to Issue Price-BCT.AX PRICE SENSITIVE17/08/16
BCT Rights Issue Offer Document-BCT.AX PRICE SENSITIVE17/08/16
BCT Rights Issue Announcement-BCT.AX PRICE SENSITIVE15/08/16
BCT Trading Halt-BCT.AX PRICE SENSITIVE11/08/16
BCT Sale to Chinese Centre for Disease, Control and Prevention-BCT.AX PRICE SENSITIVE01/08/16
BCT Open Briefing interview with MD/CEO Andrew McLellan-BCT.AX PRICE SENSITIVE11/07/16
BCT Appendix 4C - quarterly-BCT.AX PRICE SENSITIVE11/07/16
BCT Partner Activity Progress-BCT.AX PRICE SENSITIVE07/06/16
BCT Appendix 4C - quarterly-BCT.AX PRICE SENSITIVE11/04/16
BCT Appendix 4D - Preliminary Unaudited Half Year ReportPRICE SENSITIVE16/02/16
BCT Bluechiip Passes Major Milestone in OEM PartnershipPRICE SENSITIVE12/02/16
BCT Bluechiip Granted Patents in Europe and AustraliaPRICE SENSITIVE05/02/16
BCT Appendix 4C - quarterlyPRICE SENSITIVE28/01/16
BCT Share Purchase Plan Offer DocumentPRICE SENSITIVE22/01/16
BCT Capital RaisingPRICE SENSITIVE17/12/15
BCT Trading HaltPRICE SENSITIVE15/12/15
BCT License & Supply Agreement with Genea BiomedxPRICE SENSITIVE03/12/15
BCT Bluechiip Granted European PatentsPRICE SENSITIVE04/11/15
BCT Appendix 4C - quarterlyPRICE SENSITIVE27/10/15
BCT Bluechiip approved by Research ConnectionsPRICE SENSITIVE16/09/15
BCT Preliminary Final ReportPRICE SENSITIVE31/08/15
BCT Appendix 4C - quarterlyPRICE SENSITIVE30/07/15
BCT Price Query and ResponsePRICE SENSITIVE18/05/15
BCT Modified Appendix 4CPRICE SENSITIVE28/04/15
BCT Appendix 4C - quarterlyPRICE SENSITIVE27/04/15
BCT Bluechiip completes capital raisingPRICE SENSITIVE15/04/15
BCT Trading HaltPRICE SENSITIVE13/04/15
BCT Appendix 4DPRICE SENSITIVE24/02/15
BCT Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
BCT Appointmentof MDPRICE SENSITIVE08/12/14
BCT Korea DistributorPRICE SENSITIVE31/10/14
BCT Appendix 4C - quarterlyPRICE SENSITIVE24/10/14
BCT Company Update / Resignation of Managing DirectorPRICE SENSITIVE21/10/14
BCT Company UpdatePRICE SENSITIVE22/09/14
BCT Bluechiip announces Capital RaisingPRICE SENSITIVE08/09/14
BCT Response to ASX Price QueryPRICE SENSITIVE28/08/14
BCT Bluechiip Tags in Volume ProductionPRICE SENSITIVE07/08/14
BCT Preliminary Final ReportPRICE SENSITIVE01/08/14
BCT Appendix 4C - quarterlyPRICE SENSITIVE25/07/14
BCT Company UpdatePRICE SENSITIVE21/07/14
BCTShare Purchase Plan and PlacementPRICE SENSITIVE03/06/14
BCTSales in USA and EUPRICE SENSITIVE19/05/14
BCTCompany UpdatePRICE SENSITIVE15/05/14
BCTDevelopment and Commercialisation Agreement for ChinaPRICE SENSITIVE09/05/14
BCTAppendix 4C - quarterlyPRICE SENSITIVE29/04/14
BCTBluechiip announces Share Purchase PlanPRICE SENSITIVE23/04/14
BCTCompany update - first salesPRICE SENSITIVE11/04/14
BCTBluechiip signs international co-development agreementPRICE SENSITIVE24/03/14
BCTCompany UpdatePRICE SENSITIVE03/03/14
BCTHalf Yearly Report and AccountsPRICE SENSITIVE28/02/14
BCTBluechiip signs LBD as distributor for ChinaPRICE SENSITIVE19/02/14
BCTBCT signs Aus distribution agreement with OnQ SoftwarePRICE SENSITIVE13/02/14
BCTBluechiip and OnQ complete software integration projectPRICE SENSITIVE06/02/14
BCTAppendix 4C - quarterlyPRICE SENSITIVE31/01/14
BCTResignation of Managing Director / Management ChangesPRICE SENSITIVE28/01/14
BCTAsian biobanking market and new trial sitesPRICE SENSITIVE04/12/13
BCTAppendix 4C - quarterlyPRICE SENSITIVE28/10/13
BCTBCT launches new chain-of-custody evaluation productPRICE SENSITIVE16/09/13
BCTPreliminary Final ReportPRICE SENSITIVE26/08/13
BCTReinstatement to Official QuotationPRICE SENSITIVE20/08/13
BCT Broker Presentation
26/03/19PRICE SENSITIVE
BCT Open Briefing
26/02/19PRICE SENSITIVE
BCT Half Yearly Report and Accounts
25/02/19PRICE SENSITIVE
BCT Appendix 4C - quarterly
30/01/19PRICE SENSITIVE
BCT Appendix 4C - quarterly
18/10/18PRICE SENSITIVE
BCT BCT raises $1.95M in Share Purchase Plan
03/10/18PRICE SENSITIVE
BCT BCT Raises $5.5M and Announces Share Purchase Plan
10/09/18PRICE SENSITIVE
BCT Trading Halt
06/09/18PRICE SENSITIVE
BCT BCT signs three-year A$15.9M supply deal with Labcon
29/08/18PRICE SENSITIVE
BCT Preliminary Final Report
28/08/18PRICE SENSITIVE
BCT Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
BCT Open Briefing interview with MD Andrew McLellan
25/06/18PRICE SENSITIVE download Created with Sketch. 265.98KB
BCT Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
BCT Corporate Overview and March 2018 Update
14/03/18PRICE SENSITIVE
BCT Open Briefing - 1H FY18 results and outlook
27/02/18PRICE SENSITIVE
BCT Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE
BCT Labcon begins production of Bluechiip-enabled consumables
19/02/18PRICE SENSITIVE
BCT Appendix 4C - quarterly
22/01/18PRICE SENSITIVE
BCT Bluechiip receives A$1M order from US Partner
05/12/17PRICE SENSITIVE
BCT Company update - scaling production
19/10/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
17/10/17PRICE SENSITIVE
BCT Preliminary Final Report
30/08/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
27/07/17PRICE SENSITIVE
BCT Bluechiip raises $3.425M from rights issue and placement
05/07/17PRICE SENSITIVE
BCT Company Update
21/06/17PRICE SENSITIVE
BCT Rights Issue Offer Document
05/06/17PRICE SENSITIVE
BCT Rights Issue
01/06/17PRICE SENSITIVE
BCT Open Briefing with MD/CEO Andrew McLellan
27/04/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
21/04/17PRICE SENSITIVE
BCT Major Agreement Signed With Labcon North America
10/04/17PRICE SENSITIVE
BCT Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
25/01/17PRICE SENSITIVE
BCT CEO Interview / Open Briefing
08/12/16PRICE SENSITIVE
BCT BCT receives funding for over-temperature R&D
17/11/16PRICE SENSITIVE
BCT Sales of Starter Kits to two key institutions
09/11/16PRICE SENSITIVE
BCT Appendix 4C - quarterly-BCT.AX
25/10/16PRICE SENSITIVE
BCT Partnership with Planet Innovation-BCT.AX
15/09/16PRICE SENSITIVE
BCT Open Briefing - CEO Update-BCT.AX
09/09/16PRICE SENSITIVE
BCT Technology Evaluation Agreement and patent application-BCT.AX
01/09/16PRICE SENSITIVE
BCT Preliminary Final Report-BCT.AX
29/08/16PRICE SENSITIVE
BCT Rights Issue - Variation to Issue Price-BCT.AX
17/08/16PRICE SENSITIVE
BCT Rights Issue Offer Document-BCT.AX
17/08/16PRICE SENSITIVE
BCT Rights Issue Announcement-BCT.AX
15/08/16PRICE SENSITIVE
BCT Trading Halt-BCT.AX
11/08/16PRICE SENSITIVE
BCT Sale to Chinese Centre for Disease, Control and Prevention-BCT.AX
01/08/16PRICE SENSITIVE
BCT Open Briefing interview with MD/CEO Andrew McLellan-BCT.AX
11/07/16PRICE SENSITIVE
BCT Appendix 4C - quarterly-BCT.AX
11/07/16PRICE SENSITIVE
BCT Partner Activity Progress-BCT.AX
07/06/16PRICE SENSITIVE
BCT Appendix 4C - quarterly-BCT.AX
11/04/16PRICE SENSITIVE
BCT Appendix 4D - Preliminary Unaudited Half Year Report
16/02/16PRICE SENSITIVE
BCT Bluechiip Passes Major Milestone in OEM Partnership
12/02/16PRICE SENSITIVE
BCT Bluechiip Granted Patents in Europe and Australia
05/02/16PRICE SENSITIVE
BCT Appendix 4C - quarterly
28/01/16PRICE SENSITIVE
BCT Share Purchase Plan Offer Document
22/01/16PRICE SENSITIVE
BCT Capital Raising
17/12/15PRICE SENSITIVE
BCT Trading Halt
15/12/15PRICE SENSITIVE
BCT License & Supply Agreement with Genea Biomedx
03/12/15PRICE SENSITIVE
BCT Bluechiip Granted European Patents
04/11/15PRICE SENSITIVE
BCT Appendix 4C - quarterly
27/10/15PRICE SENSITIVE
BCT Bluechiip approved by Research Connections
16/09/15PRICE SENSITIVE
BCT Preliminary Final Report
31/08/15PRICE SENSITIVE
BCT Appendix 4C - quarterly
30/07/15PRICE SENSITIVE
BCT Price Query and Response
18/05/15PRICE SENSITIVE
BCT Modified Appendix 4C
28/04/15PRICE SENSITIVE
BCT Appendix 4C - quarterly
27/04/15PRICE SENSITIVE
BCT Bluechiip completes capital raising
15/04/15PRICE SENSITIVE
BCT Trading Halt
13/04/15PRICE SENSITIVE
BCT Appendix 4D
24/02/15PRICE SENSITIVE
BCT Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
BCT Appointmentof MD
08/12/14PRICE SENSITIVE
BCT Korea Distributor
31/10/14PRICE SENSITIVE
BCT Appendix 4C - quarterly
24/10/14PRICE SENSITIVE
BCT Company Update / Resignation of Managing Director
21/10/14PRICE SENSITIVE
BCT Company Update
22/09/14PRICE SENSITIVE
BCT Bluechiip announces Capital Raising
08/09/14PRICE SENSITIVE
BCT Response to ASX Price Query
28/08/14PRICE SENSITIVE
BCT Bluechiip Tags in Volume Production
07/08/14PRICE SENSITIVE
BCT Preliminary Final Report
01/08/14PRICE SENSITIVE
BCT Appendix 4C - quarterly
25/07/14PRICE SENSITIVE
BCT Company Update
21/07/14PRICE SENSITIVE
BCTShare Purchase Plan and Placement
03/06/14PRICE SENSITIVE
BCTSales in USA and EU
19/05/14PRICE SENSITIVE
BCTCompany Update
15/05/14PRICE SENSITIVE
BCTDevelopment and Commercialisation Agreement for China
09/05/14PRICE SENSITIVE
BCTAppendix 4C - quarterly
29/04/14PRICE SENSITIVE
BCTBluechiip announces Share Purchase Plan
23/04/14PRICE SENSITIVE
BCTCompany update - first sales
11/04/14PRICE SENSITIVE
BCTBluechiip signs international co-development agreement
24/03/14PRICE SENSITIVE
BCTCompany Update
03/03/14PRICE SENSITIVE
BCTHalf Yearly Report and Accounts
28/02/14PRICE SENSITIVE
BCTBluechiip signs LBD as distributor for China
19/02/14PRICE SENSITIVE
BCTBCT signs Aus distribution agreement with OnQ Software
13/02/14PRICE SENSITIVE
BCTBluechiip and OnQ complete software integration project
06/02/14PRICE SENSITIVE
BCTAppendix 4C - quarterly
31/01/14PRICE SENSITIVE
BCTResignation of Managing Director / Management Changes
28/01/14PRICE SENSITIVE
BCTAsian biobanking market and new trial sites
04/12/13PRICE SENSITIVE
BCTAppendix 4C - quarterly
28/10/13PRICE SENSITIVE
BCTBCT launches new chain-of-custody evaluation product
16/09/13PRICE SENSITIVE
BCTPreliminary Final Report
26/08/13PRICE SENSITIVE
BCTReinstatement to Official Quotation
20/08/13PRICE SENSITIVE
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $4.737M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BCT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.